Now live: Pro — the full 13F research suite for serious investorsSee pricing →
DCVC Opportunity Fund II GP, LLC

Q4 2023 · 13F-HR

DCVC Opportunity Fund II GP, LLCholdings as filed

Filed 2024-02-14 · accession 0001104659-24-023017

$80.9M
Reported value
4
Positions
2023-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
773122106Rocket Lab USA, Inc.$39.8M49.3%7,203,035CommonSOLE
75629V104RXRXRecursion Pharmaceuticals, Inc.$39.0M48.2%3,951,141CommonSOLE
76655K103RGTIRigetti Computing, Inc.$1.6M1.99%1,629,552CommonSOLE
25058X105Desktop Metal, Inc.$465,7450.58%620,166CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.